Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Bisoprolol Actavis Bisoprolol fumarate 2.5mg Tablet Actavis New Zealand Limited Niche Generics Limited, Dublin, Ireland
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Bisoprolol Actavis Bisoprolol fumarate 5mg Tablet Actavis New Zealand Limited Niche Generics Limited, Dublin, Ireland
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Bisoprolol Actavis Bisoprolol fumarate 10mg Tablet Actavis New Zealand Limited Niche Generics Limited, Dublin, Ireland
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Hizentra Normal immunoglobulin 200mg/mL Solution for injection CSL Behring (NZ) Limited CSL Behring AG, Bern, Switzerland
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Incruse Ellipta Umeclidinium bromide 74.2mcg equivalent to umeclidinium 62.5mcg Powder for inhalation GlaxoSmithKline (NZ) Limited Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Hertfordshire, United Kingdom
|
Dated this 13th day of February 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).